Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

14 November 2017 : Original article

Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients

DOI: 10.12659/AOT.904417

Ann Transplant 2017; 22:677-681

Related articles

28 Jun 2019 : Original article

Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates

Meghan Aversa, Luke Benvenuto [...]

DOI: 10.12659/AOT.915769

Ann Transplant 2019; 24:383-392

397 5 16

27 Aug 2019 : Original article

A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study

Jérôme Dumortier, Christophe Duvoux [...]

DOI: 10.12659/AOT.916041

Ann Transplant 2019; 24:506-516

418 3 53

23 Aug 2018 : Original article

Early Sirolimus-Based Immunosuppression is Safe for Lung Transplantation Patients: Retrospective, Single Arm, Exploratory Study

Jacek Wojarski, Sławomir Żegleń [...]

DOI: 10.12659/AOT.908471

Ann Transplant 2018; 23:598-607

396 7 32

11 Aug 2017 : Original article

Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation

Yutaka Hirano, Seiichiro Sugimoto [...]

DOI: 10.12659/AOT.904225

Ann Transplant 2017; 22:484-492

613 29 23

14 Mar 2013

Rapidly fatal disseminated acanthamoebiasis in a single lung transplant recipient

Kamyar Afshar, Ayana BoydKing [...]

DOI: 10.12659/AOT.883846

Ann Transplant 2013; 18:107-110

300 7 15

12 May 2014 : Original article

Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats

Ivan Matia, Peter Fellmer [...]

DOI: 10.12659/AOT.889870

Ann Transplant 2014; 19:225-232

380 7 19

29 Oct 2013

Lung cancer screening with low-radiation dose computed tomography after liver transplantation

Jose Ignacio Herrero, Gorka Bastarrika [...]

DOI: 10.12659/AOT.884021

Ann Transplant 2013; 18:587-592

331 2 14

04 Mar 2013

Incidence of malignancies in cardiac allograft recipients – a single-center experience

Małgorzata Sobieszczańska-Małek, Krzysztof Komuda [...]

DOI: 10.12659/AOT.883843

Ann Transplant 2013; 18:87-93

259 6 11

29 Jun 2012

Tacrolimus-induced nephrotoxicity and genetic variability: A review

Violette M.G.J. Gijsen, Parvaz Madadi [...]

DOI: 10.12659/AOT.883229

Ann Transplant 2012; 17(2): 111-121

560 23 24

31 Mar 2012

Malignancy after kidney transplantation

Behzad Einollahi,

DOI: 10.12659/AOT.882649

Ann Transplant 2012; 17(1): 145-146

405 1 14

07 Mar 2017 : Original article

Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1

Zheng Tang, Wei Zhai [...]

DOI: 10.12659/AOT.902002

Ann Transplant 2017; 22:128-137

294 2 16

15 Aug 2014 : Original article

Volatility of Serum Creatinine Relative to Tacrolimus Levels Predicts Kidney Transplant Rejection

Sarah Schmid, Rhonda Bryce [...]

DOI: 10.12659/AOT.890815

Ann Transplant 2014; 19:403-406

378 4 23

30 Sep 2011

Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation

Kyota Fukazawa, Seigo Nishida [...]

Ann Transplant 2011; 16(3): 139-142

392 23 25

30 Jun 2011

Malignancy after renal transplantation in the new era of immunosuppression

Ewa Watorek, Maria Boratynska [...]

Ann Transplant 2011; 16(2): 14-18

289 6 10

23 Mar 2011

Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of Tacrolimus in Chinese renal transplant patients

Ping Wu, Xuefeng Ni [...]

Ann Transplant 2011; 16(1): 54-60

324 4 23

10 Aug 2018 : Original article

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study

Florentine Garaix, Marc Stern [...]

DOI: 10.12659/AOT.908522

Ann Transplant 2018; 23:561-571

411 14 30

17 Mar 2017 : Original article

Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation

Diego Aguiar, Diego Martínez-Urbistondo [...]

DOI: 10.12659/AOT.901556

Ann Transplant 2017; 22:141-147

586 20 23

05 Jan 2016 : Original article

Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization

Kyle M. Gardiner, Susan E. Tett [...]

DOI: 10.12659/AOT.895664

Ann Transplant 2016; 21:1-11

365 7 38

06 Dec 2016 : Original article

De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors

Albino Eccher, Luigino Boschiero [...]

DOI: 10.12659/AOT.900386

Ann Transplant 2016; 21:745-754

497 5 19

23 Jun 2014 : Original article

Incidence of malignant neoplasia after heart transplantation – a comparison between cyclosporine a and tacrolimus

Uwe Fuchs, Sarah Klein [...]

DOI: 10.12659/AOT.890199

Ann Transplant 2014; 19:300-304

362 4 31

14 Nov 2014 : Original article

Myeloproliferative Neoplasms and Recurrent Thrombotic Events in Patients Undergoing Liver Transplantation for Budd-Chiari Syndrome: A Single-Center Experience

Urszula Oldakowska-Jedynak, Mateusz Ziarkiewicz [...]

DOI: 10.12659/AOT.890834

Ann Transplant 2014; 19:591-597

613 4 22

07 Aug 2013

Evolution to twice daily bolus intravenous tacrolimus: Optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant

Gregory I. Snell, Steven Ivulich [...]

DOI: 10.12659/AOT.883993

Ann Transplant 2013; 18:399-407

681 23 18

31 Dec 2003

Donor Transmitted Malignancies

Joseph Buell, Thomas M. Beebe [...]

Ann Transplant 2004; 9(1): 53-56

332 69 3

01 Aug 2004

Bone marrow transplantation in the course of hematological malignancies – Follow-up study in blood serum by 31P MRS

Małgorzata Kuliszkiewicz-Janus, Stanisław Baczyński [...]

Med Sci Monit 2004; 10(8): CR485-492

307 0 3

21 Oct 2002

Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies.

Alessandro Busca, Benedetto Bruno [...]

Med Sci Monit 2002; 8(10): RA221-232

360 1 6

In Press

29 Sep 2022 : Original article  

Risk Factors for Polyomavirus, Cytomegalovirus, and Viruria Co-Infection for Follow-Up of Renal Transplant ...

Ann Transplant In Press; DOI: 10.12659/AOT.937771  

15 Sep 2022 : Original article  

Cardiovascular Risk Factors in Patients Before and After Successful Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.935656  

14 Sep 2022 : Original article  

Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patien...

Ann Transplant In Press; DOI: 10.12659/AOT.937356  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358